Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PredictImmune logo — PredictImmune creates lab tests to guide personalized treatm...

PredictImmune

PredictImmune creates lab tests to guide personalized treatment for immune-mediated diseases such as IBD.

Founded 2017 United Kingdom Cambridge, United Kingdom 2-10 employees Grant Total: $25.10M Biopharma, Biotechnology +3

General Information

Company Name PredictImmune
Founded Year 2017
Location United Kingdom Cambridge, United Kingdom
Employees 2-10
Industries Biopharma, Biotechnology, Health Care +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with PredictImmune. To contact PredictImmune, visit predictimmune.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PredictImmune compare?

A PDF of PredictImmune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PredictImmune soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PredictImmune

PredictImmune is a pioneering company that specializes in developing laboratory tests to offer personalized treatment for immune-mediated diseases, with a specific focus on conditions such as inflammatory bowel disease (IBD). Founded in 2017, PredictImmune operates from the United Kingdom and has gained recognition for its groundbreaking research conducted at Cambridge University. The company's innovative approach involves the use of a simple blood sample to accurately identify high-risk patients prone to severe and recurrent symptoms, enabling early intervention with biologic therapy for effective treatment. This strategic method for managing IBD has garnered significant attention and support from medical professionals, patients, and payers. Notably, PredictImmune secured a grant investment on 20th March 2023, with backing from the Crohn's & Colitis Foundation, showcasing the growing confidence and interest in the company's vision and approach.

Business keywords: Predictive Medicine, Personalized Medicine, Immunology, Lab Testing, Cambridge University, Inflammatory Bowel Disease, Biologic Therapy, Medical Innovation, Research and Development

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Crohn's & Colitis Foundation
Crohn's & Colitis Foundation
20 Mar 2023
Series A £5.00M 1
Parkwalk Advisors
Parkwalk Advisors
12 May 2021
Series B €11.00M 4
Parkwalk Advisors Cambridge Innovation Capital
Parkwalk Advisors, Cambridge Innovation Capital +2
30 Jul 2019
Grant £100.00K 1
Innovate UK
Innovate UK
13 Dec 2018
Grant £4.30M 1
Wellcome Trust
Wellcome Trust
30 Apr 2018
Series A £4.70M 3
Parkwalk Advisors Wren Capital LLP
Parkwalk Advisors, Wren Capital LLP +1
08 May 2017

PredictImmune Alternatives & Competitors

View All Alternatives
PredictImmune vs
NEC OncoImmunity AS
NEC OncoImmunity AS Norway

Empowering cancer immunotherapy with artificial intelligence

Seed
42 employees
AI, Biotechnology
PredictImmune vs
Avenna Ltd
Avenna Ltd United Kingdom

Biotech Startup specialised in development of practical, precision healthcare solutions for inflamma...

6 employees
Biotechnology, Health Care
PredictImmune vs
Mill Creek Life Sciences
Mill Creek Life Sciences United States

Mill Creek Life Sciences was founded with a singular purpose in mind: to bring new solutions to acce...

Grant
8 employees
Biotechnology, Health Care
View all alternatives

FAQ About PredictImmune

PredictImmune creates lab tests to guide personalized treatment for immune-mediated diseases such as IBD.
PredictImmune was founded in 2017.
PredictImmune is headquartered in Cambridge, United Kingdom.
PredictImmune operates in Biopharma, Biotechnology, Health Care, Life Sciences and Medical Devices. Its work centres on Predictive Medicine, Personalized Medicine, Immunology and Lab Testing.
PredictImmune has approximately 2-10 employees.
PredictImmune has completed 6 funding rounds, raising a total of $25.10M. The latest funding stage is Grant.
Top alternatives and competitors to PredictImmune include NEC OncoImmunity AS, Avenna Ltd, Mill Creek Life Sciences, ImmusanT, Lab Me Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PredictImmune and NEC OncoImmunity AS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PredictImmune, https://bouncewatch.com/company/predictimmune, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes